No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GMED Globus Medical
- 50.750
- -0.450-0.88%
Close Apr 18 16:00 ET
6.87BMarket Cap47.43P/E (TTM)
51.540High50.650Low969.56KVolume51.170Open51.200Pre Close49.39MTurnover0.87%Turnover Ratio47.43P/E (Static)135.37MShares62.88052wk High1.72P/B5.68BFloat Cap43.38552wk Low--Dividend TTM111.92MShs Float84.230Historical High--Div YieldTTM1.74%Amplitude10.260Historical Low50.941Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | NYSE Order Imbalance 106557.0 Shares on Sell Side
RBC Capital Sticks to Its Buy Rating for Globus Medical (GMED)
Why Globus Medical (GMED) Is a Top Momentum Stock for the Long-Term
Why We're Not Concerned About Globus Medical, Inc.'s (NYSE:GMED) Share Price
With a price-to-earnings (or "P/E") ratio of 57.1x Globus Medical, Inc. (NYSE:GMED) may be sending very bearish signals at the moment, given that almost half of all companies in the United States have
Don't Expect Pandemic Backlog to Fuel Orthopedic Sales, Says Needham
Globus Medical (NYSE:GMED) Investors Are Sitting on a Loss of 13% If They Invested Three Years Ago
Comments
The company's CEO, Dan Scavilla, expressed confidence in Pfeil's ability to drive operational efficiency and deliver profitable growth, especially in light of the ongoing integration following their merger with NuVasive.
Press Release: Globus Medical Promotes Keith Pfeil to Chief Operating Officer and Chief Financial OfficerGlobus Medical's superior earnings outlook is contributing to its high P/E, which shareholders are currently comfortable with, expecting not to face a threat to future earnings. The confidence in the future earnings performance supports the current share price.
Globus Medical's persisting issues impact its valuation and a drop in EPS may spark shareholder worry. The long-term share performance is lackluster, unsettling even potential contrarian investors seeking a turnaround.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg